Cargando…
Differential Plasma Proteins Identified via iTRAQ-Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adenocarcinoma
OBJECTIVE: We aimed to identify differentially expressed proteins in the plasma of patients with pancreatic cancer and control subjects, which could serve as potential tumor biomarkers. METHODS: Differentially expressed proteins were determined via isostatic labeling and absolute quantification (iTR...
Autores principales: | Chen, Xiubing, Liao, Xiaomin, Zheng, Biaolin, Wang, Feng, Chen, Feiran, Deng, Zhejun, Jiang, Haixing, Qin, Shanyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883097/ https://www.ncbi.nlm.nih.gov/pubmed/36712921 http://dx.doi.org/10.1155/2023/5145152 |
Ejemplares similares
-
Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer
por: Yang, Zhe, et al.
Publicado: (2023) -
The Long Noncoding RNA Gm9866/Nuclear Factor-κB Axis Promotes Macrophage Polarization
por: Liao, Xiaomin, et al.
Publicado: (2023) -
Prediction of acute pancreatitis complications using routine blood parameters during early admission
por: Chen, Xiubing, et al.
Publicado: (2022) -
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005) -
A Proteomic Approach for Plasma Biomarker Discovery with iTRAQ Labelling and OFFGEL
Fractionation
por: Ernoult, Emilie, et al.
Publicado: (2010)